CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. (Q53294922)
Jump to navigation
Jump to search
scientific article published on 16 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. |
scientific article published on 16 October 2010 |
Statements
CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. (English)
1 reference
Setsuo Hirohashi
1 reference
Yae Kanai
1 reference
Tesshi Yamada
1 reference
Nobuyoshi Hiraoka
1 reference
Rie Yamazaki-Itoh
1 reference
Yoshinori Ino
1 reference
Yasunori Mizuguchi
1 reference
16 October 2010
1 reference
140
1 reference
1
1 reference
310-321
1 reference
Identifiers
1 reference